rs766521030

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_022166.4(XYLT1):​c.154G>A​(p.Gly52Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00135 in 1,111,762 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00091 ( 1 hom., cov: 30)
Exomes 𝑓: 0.0014 ( 6 hom. )

Consequence

XYLT1
NM_022166.4 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.110

Publications

0 publications found
Variant links:
Genes affected
XYLT1 (HGNC:15516): (xylosyltransferase 1) This locus encodes a xylosyltransferase enzyme. The encoded protein catalyzes transfer of UDP-xylose to serine residues of an acceptor protein substrate. This transfer reaction is necessary for biosynthesis of glycosaminoglycan chains. Mutations in this gene have been associated with increased severity of pseudoxanthoma elasticum.[provided by RefSeq, Nov 2009]
XYLT1 Gene-Disease associations (from GenCC):
  • Desbuquois dysplasia 2
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Desbuquois dysplasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • XYLT1-congenital disorder of glycosylation
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004581392).
BP6
Variant 16-17470643-C-T is Benign according to our data. Variant chr16-17470643-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 577084.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000912 (134/146872) while in subpopulation SAS AF = 0.00167 (8/4792). AF 95% confidence interval is 0.00125. There are 1 homozygotes in GnomAd4. There are 62 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
XYLT1NM_022166.4 linkc.154G>A p.Gly52Ser missense_variant Exon 1 of 12 ENST00000261381.7 NP_071449.1
XYLT1XM_047434458.1 linkc.154G>A p.Gly52Ser missense_variant Exon 1 of 11 XP_047290414.1
XYLT1XM_017023539.3 linkc.154G>A p.Gly52Ser missense_variant Exon 1 of 12 XP_016879028.1
LOC107987234XR_001752091.2 linkn.-216G>A upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
XYLT1ENST00000261381.7 linkc.154G>A p.Gly52Ser missense_variant Exon 1 of 12 1 NM_022166.4 ENSP00000261381.6

Frequencies

GnomAD3 genomes
AF:
0.000913
AC:
134
AN:
146762
Hom.:
1
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000563
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00167
Gnomad FIN
AF:
0.000114
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00149
Gnomad OTH
AF:
0.000494
GnomAD2 exomes
AF:
0.00119
AC:
49
AN:
41118
AF XY:
0.00120
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000149
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00155
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00142
AC:
1367
AN:
964890
Hom.:
6
Cov.:
29
AF XY:
0.00144
AC XY:
669
AN XY:
466032
show subpopulations
African (AFR)
AF:
0.000219
AC:
4
AN:
18238
American (AMR)
AF:
0.000195
AC:
2
AN:
10272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
10340
East Asian (EAS)
AF:
0.00
AC:
0
AN:
7314
South Asian (SAS)
AF:
0.00199
AC:
73
AN:
36696
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9100
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2176
European-Non Finnish (NFE)
AF:
0.00149
AC:
1244
AN:
837258
Other (OTH)
AF:
0.00131
AC:
44
AN:
33496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
80
161
241
322
402
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000912
AC:
134
AN:
146872
Hom.:
1
Cov.:
30
AF XY:
0.000867
AC XY:
62
AN XY:
71498
show subpopulations
African (AFR)
AF:
0.000562
AC:
23
AN:
40940
American (AMR)
AF:
0.000202
AC:
3
AN:
14834
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3390
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4946
South Asian (SAS)
AF:
0.00167
AC:
8
AN:
4792
European-Finnish (FIN)
AF:
0.000114
AC:
1
AN:
8752
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.00149
AC:
98
AN:
65978
Other (OTH)
AF:
0.000489
AC:
1
AN:
2046
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00171
Hom.:
1
Bravo
AF:
0.000706
ExAC
AF:
0.000874
AC:
15

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jul 24, 2019
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; In silico analysis, which includes splice predictors and evolutionary conservation, suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge -

Desbuquois dysplasia 1 Benign:1
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

XYLT1-related disorder Benign:1
May 23, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.70
CADD
Benign
18
DANN
Benign
0.96
DEOGEN2
Benign
0.012
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.039
N
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.11
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.020
N
REVEL
Benign
0.027
Sift
Benign
0.20
T
Sift4G
Benign
0.65
T
Polyphen
0.0020
B
Vest4
0.074
MVP
0.068
MPC
0.22
ClinPred
0.014
T
GERP RS
0.46
PromoterAI
-0.033
Neutral
Varity_R
0.084
gMVP
0.30
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs766521030; hg19: chr16-17564500; API